ENSOMA

Serial Number 90019881
606

Registration Progress

Application Filed
Jun 25, 2020
Under Examination
Jan 12, 2021
Approved for Publication
Nov 17, 2020
Published for Opposition
Nov 17, 2020
Registered

Trademark Image

ENSOMA

Basic Information

Serial Number
90019881
Filing Date
June 25, 2020
Published for Opposition
November 17, 2020
Abandonment Date
February 12, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 12, 2024
Classes
005

Rights Holder

ENSOMA, INC.

03
Address
451 D Street, Suite 711
Boston, MA 02210

Ownership History

Veevo Biomedicines, Inc.

Original Applicant
03
Boston, MA

ENSOMA, INC.

New Owner Before Publication #1
03
BOSTON, MA

ENSOMA, INC.

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Caitlin Byczko

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

41 events
Date Code Type Description Documents
Feb 12, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Feb 12, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 15, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 14, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 12, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Jun 12, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 18, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 16, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 16, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 16, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 13, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 11, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 11, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
May 11, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 21, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 19, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 19, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 19, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 29, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 29, 2021 NOAC E CORRECTED NOA E-MAILED Loading...
Jul 28, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 28, 2021 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Jul 19, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 23, 2021 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Jun 23, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 23, 2021 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Jun 23, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 12, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 17, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 17, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 28, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 8, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 7, 2020 ALIE A ASSIGNED TO LIE Loading...
Oct 7, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 7, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 7, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Oct 7, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 28, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 29, 2020 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 22, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 29, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for the treatment of diseases, namely, genetic diseases, infectious diseases, autoimmune diseases, diseases of oncology, hematology, immunodeficiency, and inborn errors of metabolism

Classification

International Classes
005